The Public Comment Period for Draft CMS FHIR® Digital Quality Measures (dQMs) is now open. Comment on Eligible Clinician dQMs, Hospital - Inpatient dQMs, and Hospital - Outpatient dQMs until February 25, 2026.
Top
Official websites use
.gov
A .gov website belongs to an official government organization in the United States.
Secure
.gov
websites use HTTPS
A
lock
(
)
or
https://
means you’ve safely connected to the
.gov
website. Share sensitive information only on official, secure websites.
["Allergy, Intolerance": "Statin Allergen"]
Performance/Reporting Period
2023
Value Set Description from VSAC
Clinical Focus: The purpose of this value set is to represent concepts of an allergy to statin medications.
Data Element Scope: This value set may use a model element related to Allergy/Intolerance.
Inclusion Criteria: Includes concepts that define an allergy to statin medications.
Exclusion Criteria: No exclusions.
Data Element Scope: This value set may use a model element related to Allergy/Intolerance.
Inclusion Criteria: Includes concepts that define an allergy to statin medications.
Exclusion Criteria: No exclusions.
Constrained to codes in the Allergy, Intolerance: Statin Allergen value set (2.16.840.1.113762.1.4.1110.42)
QDM Datatype and Definition
"Allergy Intolerance"
Data elements that meet criteria using this datatype should document the allergy or intolerance and its corresponding value set.
Timing:
- The prevalencePeriod references the time from the onset date to the abatement date. Often an abatement date is not present as allergy or intolerance is ongoing.
- The author dateTime references the recorded time.
eCQMs using this data element:
QDM Attributes
prevalencePeriod
prevalencePeriod is the time from onset dateTime to abatement dateTime.
Last Updated: Jul 15, 2022